Clinical Sciences Building, Division of Epidemiology and Public Health, University of Nottingham, Nottingham City Hospital, Nottingham NG5 1PB, United Kingdom.
Vaccine. 2012 Mar 2;30(11):1965-71. doi: 10.1016/j.vaccine.2012.01.020. Epub 2012 Jan 18.
To describe the custodial hepatitis B vaccination programme performance and examine these data by geographical region and prison category.
Retrospective ecological study.
Health Protection Agency (HPA) published data.
Custodial primary healthcare providers located in prisons across England and Wales.
147 prisons which reported vaccination data between July 2003 and April 2010 to the HPA Prison Infection Prevention team.
Hepatitis B vaccination coverage (July 2003 to April 2010) and uptake (December 2007 to April 2010).
Median hepatitis B vaccination coverage was 22% (interquartile range [IQR] 5-49%) and uptake was 36% (IQR 16-59%). Vaccination coverage varied significantly between July 2003 and November 2007 compared to December 2007 and April 2010 (median 12% [IQR 2-31%] versus median 48% [IQR 26-67%], Mann-Whitney W=14,689,158.0, p<0.001). There was significant variation between vaccination coverage (Kruskal-Wallis H=613.44, DF=9, p<0.001) and uptake (Kruskal-Wallis H=247.99, DF=9, p<0.001) across the HPA regions. Compared to England and Wales, estimated population median vaccination coverage was significantly (p≤0.05) lower in three regions and one prison category and higher in four regions and seven prison categories; estimated population median vaccination uptake was significantly lower in three regions and three prison categories and higher in two regions and four prison categories.
Prisoners are a vulnerable group with a high prevalence of hepatitis B infection and the custodial setting plays an important role in the delivery of hepatitis B vaccination to this hard to reach group. This study suggests that variation in hepatitis B vaccination coverage and uptake may exist by geographical region and prison category. Further research is required to confirm and identify possible explanations for our findings.
描述羁押乙肝疫苗接种项目的执行情况,并按地理位置和监狱类型对这些数据进行分析。
回顾性生态学研究。
英国公共卫生署(HPA)公布的数据。
英格兰和威尔士各监狱的羁押初级保健提供者。
2003 年 7 月至 2010 年 4 月期间,向 HPA 监狱感染预防小组报告疫苗接种数据的 147 家监狱。
2003 年 7 月至 2010 年 4 月期间的乙肝疫苗接种覆盖率(7 月至 4 月)和接种率(2007 年 12 月至 4 月)。
乙肝疫苗接种覆盖率的中位数为 22%(四分位间距[IQR]5-49%),接种率中位数为 36%(IQR 16-59%)。与 2007 年 12 月至 2010 年 4 月相比,2003 年 7 月至 11 月期间的疫苗接种覆盖率有显著差异(中位数 12%[IQR 2-31%],中位数 48%[IQR 26-67%],Mann-Whitney W=14689158.0,p<0.001)。在 HPA 地区,疫苗接种覆盖率(Kruskal-Wallis H=613.44,DF=9,p<0.001)和接种率(Kruskal-Wallis H=247.99,DF=9,p<0.001)存在显著差异。与英格兰和威尔士相比,三个地区和一个监狱类别中的估计人口中位数接种覆盖率显著较低(p≤0.05),四个地区和七个监狱类别中的估计人口中位数接种覆盖率显著较高;三个地区和三个监狱类别的估计人口中位数接种率显著较低,两个地区和四个监狱类别的估计人口中位数接种率显著较高。
囚犯是一个弱势群体,乙型肝炎感染率很高,羁押环境在向这一难以接触的人群提供乙型肝炎疫苗接种方面发挥着重要作用。本研究表明,地理位置和监狱类型可能会导致乙肝疫苗接种覆盖率和接种率的差异。需要进一步研究来证实并确定我们发现的可能原因。